| News
Early mover: NextDay.Vision is first tenant at Switzerland Innovation Park Basel Area in Jura
26.09.2019
One month before the official opening, the Jura site of the Switzerland Innovation Park Basel Area welcomes its first tenant: NextDay.Vision, a start-up from the Jura, opens its office at the park. The company was also one of the winners of the i4Challenge 2018.

Philippe Kapfer, CEO NextDay.Vision
Being in the Jura comes with advantages for the company: Customers and partners in Basel, Bern, Neuchâtel, Geneva and Paris are easily accessible by train. Being close to the many SMEs in the Jura further provides the possibility to easily deploy and improve new products, adapting them to the needs of the customers. To CEO Philippe Kapfer, the Jura site of the innovation park is the perfect place to innovate, to share and to grow. “We are convinced that the Switzerland Innovation Park Basel Area will help us in creating new partnerships and in finding new customers.” He appreciates the effort that the canton makes to attract and to keep innovative companies. “We are one of these innovators. There is no reason for us to go elsewhere,” Kapfer says.
CEO Philippe Kapfer is a cybersecurity specialist and author of a book on Internal Hacking. He founded his start-up to develop software solutions in computer security in 2017. NextDay.Vision also offers IT security consulting as well as conferences and trainings on security awareness. NextDay.Vision recently released its first product: OtpOne API replaces passwords in company business applications. “Our next plans are to develop some tools related to our technology to provide IT companies with more comfort and security. Further, we want to develop cybersecurity audits and raise awareness in order to protect local SMB companies from hackers.” NextDay.Vision also collaborates with a reseller in Canada to open new markets.
The CEO hopes for a thriving community at the innovation park and looks forward to finding complementary profiles of entrepreneurs and skills in order to work together and to create something new. Philippe Kapfer also enjoys the other qualities of the Jura: “The region is just beautiful.”
Share this article
Sign up to receive our newsletter in your inbox.
You might also be interested in
Clinerion is now part of Citeline
Clinerion has been integrated into New York-based company Citeline. Clinerion plans to expand its portfolio with Citeline’s complementary opportunities with...
Read MoreKUORI developing biodegradable plastics
The Basel-based cleantech company KUORI GmbH develops alternative materials for conventional plastics. The aim is to reduce the accumulation of...
Read MoreCell and gene therapies gain momentum in Basel
Companies specializing in the research and development of innovative cell and gene therapies continue to spring up all around the...
Read MoreBLKB expanding support for startups
BLKB offers particularly promising SMEs and startups financial support within the framework of the “100 fürs Baselbiet” program. These companies...
Read MoreCombatting the rise of antimicrobial resistance
Antimicrobial resistance (AMR) is a growing global threat that, without intervention, could lead to as many as 10 million deaths...
Read MoreAMR Action Fund invests in new antibiotics developed by BioVersys
The AMR Action Fund has made its first European investment in BioVersys, which is headquartered at Tech Park Basel. The...
Read MoreInvestors give Resistell 8.5 million Swiss francs
Resistell AG has secured 8.5 million Swiss francs in the first part of its series B funding round. The biotechnology...
Read MoreBSI integrating AI from Parashift in banking software
Parashift, the specialist in the area of smart document processing on the basis of Artificial Intelligence (AI), has entered into...
Read MoreUptownBasel joins IBM Quantum Network
UptownBasel is partnering with IBM. The emerging competence center for Industry 4.0 will provide its partners with the IBM Quantum...
Read MoreSouth Korean pharma firms show interest in the Basel Area
Several South Korean firms from the life sciences industry, including three pharmaceutical multinationals, have visited the Basel Area on fact-finding...
Read More